The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $79.63

Today's change+0.07 +0.09%
Updated September 22 4:01 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $79.63

Today's change+0.07 +0.09%
Updated September 22 4:01 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp up slightly

CVS Health Corp closed up just (U.S.)$0.07 Friday to (U.S.)$79.63. Shares have lost 4.26% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 27.01% during the last year.

Key company metrics

  • Open(U.S.) $79.20
  • Previous close(U.S.) $79.56
  • High(U.S.) $79.90
  • Low(U.S.) $78.62
  • Bid / Ask-- / --
  • YTD % change+0.91%
  • Volume6,534,109
  • Average volume (10-day)5,912,311
  • Average volume (1-month)5,146,242
  • Average volume (3-month)5,661,914
  • 52-week range(U.S.) $69.30 to (U.S.) $90.85
  • Beta0.92
  • Trailing P/E15.87×
  • P/E 1 year forward13.54×
  • Forward PEG1.68×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.51%
  • Trailing EPS(U.S.) $5.02
Updated September 22 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue45,68544,51445,97144,615
Total other revenue--------
Total revenue45,68544,51445,97144,615
Gross profit6,9356,5807,6067,492
Total cost of revenue38,75037,93438,36537,123
Total operating expense43,56842,72142,97641,899
Selling / general / administrative4,8184,7874,6114,675
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0--0101
Other operating expenses, total--------
Operating income2,1171,7932,9952,716
Interest income (expense), net non-operating-251-258-248-258
Gain (loss) on sale of assets--------
Other--------
Income before tax1,8631,5342,7532,463
Income after tax1,0979621,7071,542
Income tax, total7665721,046921
Net income1,0989521,7071,540
Total adjustments to net income-45-9-6
Net income before extra. items1,0979611,7071,541
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0939661,6981,535
Inc. avail. to common incl. extra. items1,0949571,6981,534
Diluted net income1,0949571,6981,534
Dilution adjustment--------
Diluted weighted average shares1,0241,0351,0701,073
Diluted EPS excluding extraordinary itemsvalue per share1.070.931.591.43
Dividends per sharevalue per share0.500.500.430.43
Diluted normalized EPSvalue per share1.070.931.591.49